高剂量阿莫西西林和潘托普拉治疗方案用于杆菌根除:一个多中心,跨国随机对照试验
Pezhman Alavinejad1, Samira Mohamadi1, Mohammad Javad Rezaei1
1Alimentary Tract Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Przeglad gastroenterologiczny
|July 7, 2025
概括
高剂量的阿莫西西林-潘托普拉双疗法显示,与基于克拉里胺的四重疗法相比,Helicobacter pylori根除率较低. 尽管副作用增加,但克拉里斯罗米辛疗法更有效.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- * 杆菌 (HP) 感染是一个全球性的健康问题,需要有效的根除策略.
- *目前的治疗指南建议使用各种方案,但耐药性和疗效各不相同.
- *正在不断研究新的治疗方法,以提高HP根除率.
研究的目的:
- * 为了比较高剂量阿莫西西林和潘托普拉双疗法与基于克拉里斯罗米辛的四重疗法对HP根除的疗效.
- * 评估两个治疗组之间的根除率,不良事件和合规性.
主要方法:
- *一项双盲随机受控试验 (RCT) 涉及3个国家的619名确诊HP感染的患者.
- *参与者接受了高剂量阿莫西西林-潘托普拉双疗法或基于克拉里思罗米辛的四重疗法,持续两周,其次是潘托普拉.
- *使用治疗意图 (ITT) 和每协议 (PP) 分析评估HP根除.
主要成果:
- * 基于克拉里胺的四重疗法实现了明显更高的根除率 (ITT: 85.6%,PP: 89.8%) 与双重治疗 (ITT: 68.3%,PP: 72.2%) 相比 (p < 0.0001).
- *双治疗组的不良事件较少 (22.0%) 比四重治疗组 (40.1%) (p < 0.0001).
- *两个组的完全合规率相似 (90.7%对89.0%,p=0.718).
结论:
- *高剂量阿莫西西林-潘托普拉双疗法在HP根除方面效果不如基于克拉里胺的四重疗法.
- * 基于克拉利胺的四重疗法提供了更高的根除率,尽管与更多的副作用有关.
- *治疗选择应平衡疗效,耐受性和患者特定因素.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
555
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
555
01:26Peptic Ulcer Disease IV: Management
148
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
148
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
206
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
206
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
530
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
530
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
573
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
573
01:30Peptic Ulcer Disease I: Introduction
300
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
300